Association of Quality of Life Measures and Otolaryngologic Care in Cystic Fibrosis Patients.

Abstract

OBJECTIVES\nAppropriate management of chronic rhinosinusitis (CRS) among patients with cystic fibrosis (CF) is important in improving quality of life. Otolaryngologists play a critical role in reducing CRS symptom burden. This study seeks to evaluate the role of patient-reported quality-of-life measures in guiding interventions for CF-related sinus disease.\n\n\nMETHODS\nWe performed a prospective, cross-sectional study of 105 patients presenting to a CF-accredited clinic between July and September 2018. Demographic data and sinus surgery history were collected, in addition to Sino-Nasal Outcome Test (SNOT-22) and Questionnaire of Olfactory Disorders (QOD-NS) scores. Statistical analysis was conducted using correlation and non-parametric Mann-Whitney U tests.\n\n\nRESULTS\nBaseline well-care visits accounted for 71.4% of all clinical evaluations. Prior otolaryngology intervention was noted in 69 (66%) patients, where the majority of these patients (63/69; 91%) underwent endoscopic sinus surgery (ESS). Patients with a history of otolaryngology intervention had an average SNOT-22 score of 33.2 (SD\u2009=\u200920.6) compared to 24.9 (SD\u2009=\u200918.5) for patients without prior intervention (P\u2009=\u2009.048). The average QOD-NS score was 5.5 (SD\u2009=\u20096.4) among patients referred to otolaryngologists and 3.1 (SD\u2009=\u20095.7) for non-referred patients (P\u2009=\u2009.012). SNOT-22 and QOD-NS scores were modestly correlated (R of .43).\n\n\nCONCLUSION\nCF patients with symptoms resulting in worse quality-of-life assessments were more likely to have established coordinated care with an otolaryngologist. Further validation of the utility of SNOT-22 and QOD-NS questionnaires as care coordination metrics is necessary in the CF population.